Atorvia Health Technologies

A commercially focused Biotech advancing ground breaking technologies to transform outcomes for patients with organ failure, starting with the kidney.

[Atorvia Health Technologies @atorvia_co]

@OBIOscience @BIOTECanada @MississaugaEDO 💙

[Atorvia Health Technologies @atorvia_co]

Atorvia has graduated from the highly competitive, prestigious accelerator #CreativeDestructionLabs 🎊

[Atorvia Health Technologies @atorvia_co]

Delighted to have won the “bio pharmaceuticals and biotechnologies” prize sponsored by @JnJ. Congrats also to @CereCura and #integratednanotherapeuticsfor their big wins!

[Atorvia Health Technologies @atorvia_co]

Or even #InvestOttawa !

[Atorvia Health Technologies @atorvia_co]

Our team just applied to Startup World Cup @SW2023 #Atorvia #StartupWorldCup. Thanks @InvestOttawa for the share 🎉

[Atorvia Health Technologies @atorvia_co]

Our team just applied to Startup World Cup @SW2023 #Atorvia #StartupWorldCup. Thanks @InvestOttawa for the share 🎉

[Atorvia Health Technologies @atorvia_co]

Proudly joining wet lab incubator @SpinUpUTM on #UTM campus, thrilled to be @Merck Blue Ticket winners, even more focused on advancing kidney failure treatments.

[U of T Mississauga @UTM]

#UTM wet lab incubator SpinUp (@SpinUpUTM) names kidney therapy startup Atorvia as first @Merck Blue Ticket winner 🔗 https://t.co/3vZXB8NIzE

[U of T Mississauga @UTM]

#UTM wet lab incubator SpinUp (@SpinUpUTM) names kidney therapy startup Atorvia as first @Merck Blue Ticket winner 🔗 https://t.co/3vZXB8NIzE

[Atorvia Health Technologies @atorvia_co]

Beyond thrilled to be moving in to @SpinUpUTM AND on winning the Blue Ticket. The financial support and mentoring from @Merck and the facilities and programming at SpinUp will truly help us to accelerate and get our kidney treatment to patients faster.

[U of T Mississauga @UTM]

#UTM wet lab incubator SpinUp (@SpinUpUTM) names kidney therapy startup Atorvia as first @Merck Blue Ticket winner 🔗 https://t.co/3vZXB8NIzE

[SpinUpUTM @SpinUpUTM]

Congratulations to the Atorvia team! The emerging woman-led biotech company is SpinUp's first-ever Blue Ticket winner. Learn about their mission to treat acute kidney injury — and how @Merck's mentorship and support will help Atorvia reach its goal.

[OBIO @OBIOscience]

Happy to count @atorvia_co among so many amazing companies presenting at #OIS2024 this week!

#OBIOInvestmentSummit #OBIO #OBIOInvestmentSummit2024

[Atorvia Health Technologies @atorvia_co]

We are thrilled to be presenting to global investors at the 2024 #OBIOInvestmentSummit! The Summit features Canada’s most investible health science companies commercializing products & services in therapeutics, medical devices, diagnostics & more.
https://t.co/FyYo8iZZno

[Atorvia Health Technologies @atorvia_co]

Great to meet the MBD22 Fall cohort and hear the pitches. Another great MassBio program under wraps!

[MassBio @MassBio]

We learned, laughed and networked! No doubt these innovators will change the course of the life sciences

[Jane Lapon @janelapon]

Congrats to the Fall cohort!

[Atorvia Health Technologies @atorvia_co]

Looking forward to meeting the new cohort next week at the @MassBio Fall Mixer!

#MBDF22 #innovation #startups #biotech

[Joe Boncore @joeboncore]

Cost should never be a barrier to patients accessing the care they need. Unfortunately, Congress has created a proposal that will not reduce costs for individual patients, and is likely to disincentivize investment, hog-tie innovation, and cost jobs. https://t.co/0WzUBddL0S

[MassBio @MassBio]

Join @EMDSerono @TakedaPharma & @AstraZeneca for #lifesciences’ premier innovation summit! Our #PartneringWeek is an interactive experience that connects emerging companies with the partners & resources they need to take their businesses to the next level. https://t.co/z1cMq1qOO5

[MassBio @MassBio]

We recently sat down with the founders from #MassBioDrive’s spring 2022 cohort to learn a little more about their experience in the program and plans beyond the accelerator. Check out what they had to say (and apply by July 1 to join the fall 2022 cohort) https://t.co/wObFzlalVJ

[Jane Lapon @janelapon]

Some insight from the CEO’s of the #MBDS22 cohort about the ⁦@MassBio⁩ program, how it benefited our businesses and what progress we were all able to make as a result.

Applications for the fall are still open!
https://t.co/7ThidBHbZa

[Atorvia Health Technologies @atorvia_co]

We encourage you to apply!

[MassBio @MassBio]

@atorvia_co CEO on her #MassBioDrive experience: “The program was transformational. It got us ready to launch an efficient and effective capital raise process for seed funding.”
To join the next cohort, apply by 7/1: https://t.co/mNKwjAtkC8

[Jane Lapon @janelapon]

Starting a biotech is complex & challenging - but it’s also a gift. As an industry, we are developing tech that has the potential to transform the lives of patients. Accelerators like MassbioDrive helps biotechs to be successful beyond the science. https://t.co/1jIE93UvGh